ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01139359
Recruitment Status : Withdrawn (Study enrollment was withdrawn as it is no longer the sponsor's intention to study this indication under this protocol.)
First Posted : June 8, 2010
Last Update Posted : July 19, 2012
Sponsor:
Information provided by (Responsible Party):
Ziopharm

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2011
  Estimated Study Completion Date : June 2011